False Treatment Claims Still A COVID-19 Symptom: FTC Files Complaint Against California Firm

 
• By Malcolm Spicer

FTC files complaint alleging Precision Patient Outcomes marketed a supplement as a treatment to mitigate the effects of COVID-19 after agency let the firm know it considered the claims false advertising.

FTC alleges Precision Patient Outcomes changed the name of its product from COVID Resist to VIRUS Resist after the agency questioned advertising claiming it’s treatment for COVID-19. • Source: Federal Trade Commission

More from Archive

More from HBW Insight